JAKARTA – PT Prodia Widyahusada Tbk (PRDA), the Prodia clinics and laboratories managing company, scores IDR 301.02 billion of net profit and IDR 1.2 trillion of revenue in the first half of 2021. President Director of Prodia, Dewi Muliaty, reveals these gains in the information disclosure, quoted Wednesday (4/8).
“We are standing on a solid financial position and trying to secure revenue and profit to generate higher returns to the shareholders and the company’s stakeholders,” Muliaty adds.
According to Muliaty, the primary contributor of the revenue gain is the individual and doctor-referenced customers, bringing in 68.19%. Then, the third-part-referenced customers and corporate clients follow with 31.81% contribution. In general, the net profit margin and EBITDA margin soar 24.3% and 39.5%, respectively. Meanwhile, the current ratio and quick ratio are at 663.1% and 638.4%. “These gains indicate how Prodia’s balance is getting stronger,” Muliaty concludes.
It is also revealed that the company has handled 8 million health check-ups. They include genomic tests, routine check-ups, COVID-19 tests, and other medical check-ups throughout the first half of 2021. Lastly, the request for esoteric testing has reached 1 million tests in the same period. (LK/ZH)